ROSELLA

Created using ChatSlide

Discover the comprehensive findings of the ROSELLA Trial, a pivotal Phase 3 study, through a keynote presentation that delves into its methodology, treatment comparisons, and significant outcomes concerning relacorilant versus monotherapy. Attendees will gain insights into key safety profiles, subgroup analyses, and how these findings pave the way for a new standard of care in ovarian cancer. With a focus on regulatory milestones and global collaborations, this presentation will highlight...